NASDAQ:EYES

Second Sight Medical Products - EYES Stock Forecast, Price & News

Notice: This company has been marked as potentially delisted and may not be actively trading.

Add

Compare

Today's Range: N/A
50-Day Range: $4.11
▼
$13.05
52-Week Range: N/A

Volume: 36,800 shs
Average Volume: 132,982 shs
Market Capitalization: $54.38 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

About Second Sight Medical Products (NASDAQ:EYES) Stock

Second Sight Medical Products, Inc. develops, manufactures, and markets implantable visual prosthetics that are intended to deliver artificial vision to blind individuals. It develops technologies to treat the population of sight-impaired individuals. The company offers the Orion Visual Cortical Prosthesis System, an implanted cortical stimulation device, which is intended to provide useful artificial vision to individuals who are blind due to various causes, including glaucoma, diabetic retinopathy, optic nerve injury or disease, and eye injury. The company was founded in 1998 and is headquartered in Sylmar, California.

Receive EYES Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Second Sight Medical Products and its competitors with MarketBeat's FREE daily newsletter.

EYES Stock News Headlines

November 13, 2022 | seekingalpha.com

Sight Sciences, Inc. (SGHT) Q3 2022 Earnings Call Transcript

October 11, 2022 | marketwatch.com

Bionic Eye Market Research Technology Outlook 2022-2028 – Retina Implant AG, Bionic Vision Australia

October 4, 2022 | fool.com

Second Sight Medical Products (NASDAQ: EYES)

September 1, 2022 | reuters.com

Vivani Medical Inc

August 31, 2022 | finance.yahoo.com

Vivani Announces Trading under New Ticker Symbol (Nasdaq: VANI)

August 30, 2022 | finance.yahoo.com

Second Sight Medical Products Announces Successful Completion of its Merger with Nano Precision Medical and its Name Change to Vivani Medical, Inc.

August 21, 2022 | seekingalpha.com

Second Sight Medical sheds ~17% after reverse stock split

August 13, 2022 | msn.com

Eye implant made from pig protein restored sight in 14 blind people

July 29, 2022 | finance.yahoo.com

Second Sight Medical Products, Inc. Announces Shareholder Approval for Proposed Merger with Nano Precision Medical, Inc. and other Results of 2022 Annual Meeting

June 29, 2022 | washingtonpost.com

My miscarriage looked like an abortion. Today, I would be a suspect.

April 14, 2022 | finance.yahoo.com

Nano Precision Medical Co-Founder and CEO Discusses Proposed Second Sight Merger in Interview to Air on Bloomberg U.S. on the RedChip Money Report®

February 17, 2022 | benzinga.com

SECOND SIGHT MEDICAL INVESTOR ALERT BY THE FORMER...

February 16, 2022 | finance.yahoo.com

EYES Stock Pops on Biotech Merger Plans. 5 Things to Know.

February 8, 2022 | finance.yahoo.com

Second Sight Medical To Merge With AstraZeneca-Backed Nano Precision Medical

February 8, 2022 | benzinga.com

Second Sight Medical Shares To Resume Trade At 5 p.m. EST

February 8, 2022 | msn.com

6 high-tech tools that will take your beauty routine to the next level

February 7, 2022 | seekingalpha.com

Second Sight Medical Products to acquire Nano Precision Medical in all-stock deal

February 7, 2022 | finance.yahoo.com

Second Sight Medical Products and Nano Precision Medical Announce Merger Agreement to Create Leading Therapeutic Implant Company

February 3, 2022 | cnet.com

Get two glasses for the price of one with DIFF eyewear's BOGO sale

November 11, 2021 | nz.finance.yahoo.com

eSight Certified as a Great Place to Work® for Second Year in a Row

October 22, 2021 | msn.com

A forensic analysis of Blackburn’s infamous Venky’s chicken advert

October 21, 2021 | finance.yahoo.com

With Market Size Valued at $14.3 Billion by 2026, it`s a Healthy Outlook for the Global Neuroprosthetics Market

August 29, 2021 | msn.com

20 Bad Habits That Could Turn You Blind, Say Experts

August 11, 2021 | finance.yahoo.com

Second Sight Medical Products Announces a New NIH Grant Supplement for Its Orion Study

July 15, 2021 | nasdaq.com

Second Sight Medical Products, Inc. Common Stock (EYES)

See More Headlines

Receive EYES Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Second Sight Medical Products and its competitors with MarketBeat's FREE daily newsletter.

EYES Company Calendar

Last Earnings: 6/29/2020
Today: 12/01/2022
Fiscal Year End: 12/31/2022

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Electromedical Equipment
Sub-Industry: N/A
Sector: Medical
Current Symbol: NASDAQ:EYES
CUSIP: N/A
CIK: 1266806
Web: www.secondsight.com
Phone: (818) 833-5000
Fax: 818-833-5067
Employees: 15
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-8,920,000.00
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: -13.58%
Return on Assets: -13.02%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 22.15
Quick Ratio: 22.15

Sales & Book Value

Annual Sales: $3.38 million
Price / Sales: 0.00
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $4.80 per share
Price / Book: N/A

Miscellaneous

Outstanding Shares: 13,135,000
Free Float: 6,935,000
Market Cap: $54.38 million
Optionable: Optionable
Beta: 2.55

Key Executives

Mr. Scott Dunbar (Age 64)
Acting Chief Exec. Officer
Comp: $301.39k

Mr. Edward Jonathon Sedo (Age 66)
Acting Chief Accounting Officer, Principal Financial Officer & Controller
Comp: $199.18k

Mr. Edward David Randolph (Age 64)
Chief Operating Officer
Comp: $366.44k

Gunnar Bjorg
Founder

Ms. Lisa M. Wilson (Age 57)
Founder & Pres of In-Site Communications and Investor Relations for Second Sight

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

EYES Stock - Frequently Asked Questions

How were Second Sight Medical Products' earnings last quarter?: Second Sight Medical Products, Inc. (NASDAQ:EYES) posted its quarterly earnings data on Monday, June, 29th. The medical device company reported ($1.71) earnings per share for the quarter, missing analysts' consensus estimates of ($1.23) by $0.48.
When did Second Sight Medical Products' stock split?: Shares of Second Sight Medical Products reverse split on the morning of Friday, August 19th 2022. The 1-3 reverse split was announced on Friday, August 19th 2022. The number of shares owned by shareholders was adjusted after the closing bell on Friday, August 19th 2022. An investor that had 100 shares of stock prior to the reverse split would have 33 shares after the split.
What is Will McGuire's approval rating as Second Sight Medical Products' CEO?: 5 employees have rated Second Sight Medical Products Chief Executive Officer Will McGuire on Glassdoor.com. Will McGuire has an approval rating of 57% among the company's employees. This puts Will McGuire in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.
What other stocks do shareholders of Second Sight Medical Products own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Second Sight Medical Products investors own include Zynerba Pharmaceuticals (ZYNE), Adaptimmune Therapeutics (ADAP), Cara Therapeutics (CARA), VBI Vaccines (VBIV), Shopify (SHOP), Corbus Pharmaceuticals (CRBP), Sorrento Therapeutics (SRNE), Ekso Bionics (EKSO) and OPKO Health (OPK).

When did Second Sight Medical Products IPO?: (EYES) raised $32 million in an IPO on Wednesday, November 19th 2014. The company issued 3,500,000 shares at a price of $9.00 per share. MDB Capital Group, LLC served as the underwriter for the IPO.
What is Second Sight Medical Products' stock symbol?: Second Sight Medical Products trades on the NASDAQ under the ticker symbol "EYES."
Who are Second Sight Medical Products' major shareholders?: Second Sight Medical Products' stock is owned by many different institutional and retail investors. Top institutional shareholders include Cutler Group LLC CA (0.00%). Insiders that own company stock include Gregg Williams and Jonathan Will Mcguire.
View institutional ownership trends.
How much money does Second Sight Medical Products make?: Second Sight Medical Products (NASDAQ:EYES) has a market capitalization of $0.00 and generates $3.38 million in revenue each year.
How can I contact Second Sight Medical Products?: Second Sight Medical Products' mailing address is 12744 SAN FERNANDO ROAD SUITE 400, SYLMAR CA, 91342. The official website for the company is www.secondsight.com. The medical device company can be reached via phone at (818) 833-5000, via email at investors@secondsight.com, or via fax at 818-833-5067.

This page (NASDAQ:EYES) was last updated on 12/1/2022 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Second Sight Medical Products - EYES Stock Forecast, Price & News

About Second Sight Medical Products (NASDAQ:EYES) Stock

EYES Stock News Headlines

EYES Company Calendar

Industry, Sector and Symbol

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

Insiders & Institutions

EYES Stock - Frequently Asked Questions

About MarketBeat

Popular Tools

Financial Calendars

Terms & Info